Annette Hubsch

555 total citations
14 papers, 354 citations indexed

About

Annette Hubsch is a scholar working on Immunology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Annette Hubsch has authored 14 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Surgery and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Annette Hubsch's work include Atherosclerosis and Cardiovascular Diseases (6 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Lipoproteins and Cardiovascular Health (3 papers). Annette Hubsch is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (6 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Lipoproteins and Cardiovascular Health (3 papers). Annette Hubsch collaborates with scholars based in United Kingdom, Italy and United States. Annette Hubsch's co-authors include Joseph Cheriyan, Ian B. Wilkinson, Parag Gajendragadkar, Kaisa Mäki-Petäjä, Martin Serg, Carmel M. McEniery, Stacey S. Hickson, Simon Bond, Giuseppe Schillaci and Giacomo Pucci and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Annette Hubsch

12 papers receiving 344 citations

Peers

Annette Hubsch

CCM

IMMUN

BIOCH

SURGE

Astrid Hirt Switzerland

Ching‐Shan Huang Taiwan

Anne Cogny France

Moon Kwoun United States

Chiemi Sakai Japan

L. Redaelli Italy

Michinori Takashina Japan

Megan T. Quintana United States

Meital Cohen-Mazor Israel

Elisabeth C. Samouilidou Greece

Astrid Hirt Switzerland

Annette Hubsch

110 ×0.8

CCM

149 ×1.5

IMMUN

76 ×1.0

BIOCH

137 ×2.0

48 ×0.8

SURGE

Citations per year, relative to Annette Hubsch Annette Hubsch (= 1×) peers Astrid Hirt

Countries citing papers authored by Annette Hubsch

Since Specialization

Citations

This map shows the geographic impact of Annette Hubsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Hubsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Hubsch more than expected).

Fields of papers citing papers by Annette Hubsch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette Hubsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Hubsch. The network helps show where Annette Hubsch may publish in the future.

Co-authorship network of co-authors of Annette Hubsch

This figure shows the co-authorship network connecting the top 25 collaborators of Annette Hubsch. A scholar is included among the top collaborators of Annette Hubsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Hubsch. Annette Hubsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Mäki-Petäjä, Kaisa, et al.. (2024). Cardiovascular responses to experimental weight gain in humans: a feasibility study. Journal of Hypertension. 42(11). 2011–2017.

Zhao, Tian, Stephen P. Hoole, Simon Bond, et al.. (2024). Abstract 4144964: Low-Dose IL-2 Lowers Arterial Inflammation and Trends Towards Lower MACE in patients with ACS: The results of the IVORY trial and IVORY FINALE study. Circulation. 150(Suppl_1). 1 indexed citations

Sriranjan, Rouchelle, Tian Zhao, Jason M. Tarkin, et al.. (2022). Low-dose i nterleukin 2 for the reduction of v ascular inflammati o n in acute corona ry syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial. BMJ Open. 12(10). e062602–e062602. 32 indexed citations

Kostapanos, Michael S., Joanna Helmy, Annette Hubsch, et al.. (2021). Investigating the Lowest Threshold of Vascular Benefits from LDL Cholesterol Lowering with a PCSK9 mAb Inhibitor (Alirocumab) in Patients with Stable Cardiovascular Disease (INTENSITY-HIGH): protocol and study rationale for a randomised, open label, parallel group, mechanistic study. BMJ Open. 11(4). e037457–e037457. 4 indexed citations

Kostapanos, Michael S., Annette Hubsch, Joanna Helmy, et al.. (2021). THE EFFECTS OF ALIROCUMAB VERSUS EZETIMIBE ON TOP OF STATINS ON VASCULAR INFLAMMATION AND FUNCTION. Journal of the American College of Cardiology. 77(18). 159–159. 1 indexed citations

Mäki-Petäjä, Kaisa, Adam McGeoch, Lucy Yang, et al.. (2021). Mechanisms Underlying Vascular Endothelial Growth Factor Receptor Inhibition–Induced Hypertension. Hypertension. 77(5). 1591–1599. 25 indexed citations

Zhao, Tian, Rouchelle Sriranjan, Annette Hubsch, et al.. (2020). Low dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndrome (LILACS). European Heart Journal. 41(Supplement_2). 8 indexed citations

Kostapanos, Michael S., et al.. (2019). Investigating the lowest threshold of vascular benefits from LDL cholesterol lowering with a PCSK9 mAb inhibitor (alirocumab) in healthy volunteers – a mechanistic physiological study (INTENSITY-LOW): protocol and study rationale. PubMed. 8(1). 167–174. 1 indexed citations

Zhao, Tian, Michael S. Kostapanos, Charmaine Griffiths, et al.. (2018). Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial. BMJ Open. 8(9). e022452–e022452. 87 indexed citations

10.

Gajendragadkar, Parag, Annette Hubsch, Kaisa Mäki-Petäjä, et al.. (2014). Effects of Oral Lycopene Supplementation on Vascular Function in Patients with Cardiovascular Disease and Healthy Volunteers: A Randomised Controlled Trial. PLoS ONE. 9(6). e99070–e99070. 98 indexed citations

11.

Gajendragadkar, Parag, Annette Hubsch, Kaisa Mäki-Petäjä, et al.. (2012). Abstract 10021: Oral Lycopene Supplementation Improves Endothelial Function in Patients with Cardiovascular Disease: A Randomised Controlled Trial. Circulation. 126.

12.

Pucci, Giacomo, Joseph Cheriyan, Annette Hubsch, et al.. (2012). Evaluation of the Vicorder, a novel cuff-based device for the noninvasive estimation of central blood pressure. Journal of Hypertension. 31(1). 77–85. 95 indexed citations

13.

Pucci, Giacomo, Joseph Cheriyan, Annette Hubsch, et al.. (2010). VALIDATION OF VICORDER & SPHYGMOCOR WITH INVASIVE BLOOD PRESSURE: PP.10.395. Journal of Hypertension. 28. e168–e168. 1 indexed citations

14.

Pucci, Giacomo, Joseph Cheriyan, Annette Hubsch, et al.. (2010). 3.2 A COMPARISON OF THE VICORDER APPARATUS WITH SPHYGMOCOR DEVICE FOR THE NON-INVASIVE ASSESSMENT OF AORTIC BLOOD PRESSURE: AN INVASIVE VALIDATION STUDY. Artery Research. 4(4). 146–146. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact